A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases

Clinical trial NCT07413341 · RECRUITING

Trial details

NCT number: NCT07413341
Sponsor: Therorna
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE)Sjogren's Syndrome (SS)Systemic Sclerosis (SSc)Inflammatory Myopathy ANCA Associated Systemic Vasculitis

Start date: 2026-01-22
Primary completion: 2026-05-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.